Article info
Commentary
A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal
- Correspondence to Dr Camille Sureau, Laboratoire de Virologie Moléculaire, INSERM-U1134, INTS, 6 rue Alexandre-Cabanel, Paris 75739, France; csureau{at}ints.fr
Citation
A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal
Publication history
- Received October 27, 2015
- Revised October 29, 2015
- Accepted October 30, 2015
- First published November 26, 2015.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/